FRPT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Freshpet Inc (FRPT) does not present a strong buy opportunity for a beginner, long-term investor at this time. While the company has shown solid financial growth and hedge funds are increasing their positions, the recent price decline, ongoing legal and advertising issues, and mixed analyst ratings suggest caution. The lack of strong proprietary trading signals and the absence of significant positive catalysts further support a hold recommendation.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 59.565, and moving averages are converging, showing no clear trend. The stock is trading below its pivot point of 64.013, with key resistance at 68.895 and support at 59.131. Overall, technical indicators suggest a neutral to slightly bearish outlook.
Hedge funds are significantly increasing their positions, with an 830.08% increase in buying over the last quarter. Financial performance in Q4 2025 showed strong growth, with revenue up 8.57% YoY, net income up 86.60% YoY, and EPS up 66.67% YoY.
Freshpet is under investigation for potential securities fraud and unlawful business practices. The BBB National Programs' advertising division has recommended discontinuing certain claims, which could damage brand reputation. Analysts have mixed ratings, with some lowering price targets due to competitive pressures and cost inflation concerns. Additionally, the stock has experienced a significant price decline recently, with a -2.11% regular market change and -1.77% post-market change.
In Q4 2025, Freshpet reported revenue growth of 8.57% YoY, net income growth of 86.60% YoY, and EPS growth of 66.67% YoY. Gross margin improved to 43.54%, up 2.50% YoY, indicating strong operational performance.
Analyst ratings are mixed. DA Davidson raised the price target to $101 with a Buy rating, citing market share acceleration and stable category performance. TD Cowen upgraded the stock to Buy, highlighting competitive advantages. However, BofA, Wells Fargo, and Deutsche Bank lowered price targets due to concerns about competition, cost inflation, and potential demand destruction. The average price target is around $80, with a mix of Buy, Neutral, and Hold ratings.
